SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

BL Haagmans, D Noack, NMA Okba… - The Journal of …, 2021 - academic.oup.com
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …
被引用次数：56 相关文章
[HTML] europepmc.org

[HTML][HTML] SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

BL Haagmans, D Noack, NM Okba, W Li, C Wang… - 2020 - europepmc.org
Effective clinical intervention strategies for COVID-19 are urgently needed. Although several
clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing …

SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

BL Haagmans, D Noack, NMA Okba, W Li… - The Journal of … - ncbi.nlm.nih.gov
Effective clinical intervention strategies for COVID-19 are urgently needed. Although several
clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing …
[PDF] archive.org

[PDF][PDF] SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

BL Haagmans, D Noack, NMA Okba, W Li, C Wang… - 2021 - scholar.archive.org
Accepted Manuscript Page 1 Accepted Manuscript © The Author(s) 2021. Published by
Oxford University Press for the Infectious Diseases Society of America. All rights reserved …
[PDF] academia.edu

[PDF][PDF] SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

BL Haagmans, D Noack, NMA Okba, W Li… - The Journal of …, 2021 - academia.edu
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

BL Haagmans, D Noack, NMA Okba… - The Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …

SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

BL Haagmans, D Noack, NMA Okba… - The Journal of …, 2021 - academic.oup.com
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …

SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model.

BL Haagmans, D Noack, NMA Okba, W Li, C Wang… - 2021 - cabidigitallibrary.org
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …
[PDF] researchgate.net

[PDF][PDF] SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model

BL Haagmans, D Noack, NMA Okba, W Li… - The Journal of …, 2021 - researchgate.net
Effective clinical intervention strategies for coronavirus disease 2019 (COVID-19) are
urgently needed. Although several clinical trials have evaluated use of convalescent plasma …

SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model

BL Haagmans, D Noack, NMA Okba, W Li, C Wang… - bioRxiv, 2020 - biorxiv.org
Effective clinical intervention strategies for COVID-19 are urgently needed. Although several
clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing …